Navigation Links
State Report Ranks LIJ as New York's Best Hospital for Angioplasty Survival
Date:4/4/2008

Same report also recognizes performance of North Shore cardiologist

NEW HYDE PARK, N.Y., April 4, 2008 /PRNewswire/ -- A new state report shows that Long Island Jewish (LIJ) Medical Center in New Hyde Park was ranked the best hospital in New York for angioplasty success rates. LIJ was the only hospital to receive a prestigious double-star ranking, meaning its outcomes were significantly better from a statistical standpoint than the statewide average. Angioplasty is a procedure used to clear blocked heart arteries and increase blood flow.

The latest three-year report (encompassing data from 2003-05), released on Wednesday by the New York State Department of Health (DOH), reviewed risk- adjusted angioplasty outcomes for 50 hospitals and more than 300 cardiologists performing the procedure. The report showed that Lawrence Y. Ong, MD, director of interventional cardiology at North Shore University Hospital (NSUH), was among four cardiologists in New York State with superior outcomes.

During the three-year period, LIJ had an angioplasty caseload of 5,238 and a risk-adjusted mortality rate (RAMR) of 0.64 percent, marking the fourth consecutive report in which the hospital's outcomes were significantly better than the statewide average. It was the first time that a hospital has received a double star for four consecutive releases since New York State began to track angioplasty outcomes in 1995. LIJ was also one of only two hospitals in New York -- and the only one in the New York metropolitan area -- that had significantly better angioplasty outcomes involving patients who suffered heart attacks (a RAMR of 1.51 percent).

"Being the only hospital in New York State to get a double star for angioplasty outcomes for four consecutive years is an extraordinary achievement for LIJ cardiologists and their staff," said Stacey Rosen, MD, chief of cardiology at LIJ. "But the true winners are our patients in Queens and Long Island who have access to our top-ranking cardiologists and our services."

Included in the DOH report is the collective risk profile of the angioplasty patients for each hospital and physician. "With the Health Department's most recent report, consumers have an opportunity to review the clinical outcomes of hospitals and cardiologists performing angioplasty in their region and make an informed decision about their healthcare choices," said Stanley Katz, MD, senior vice president of cardiovascular services for the North Shore-LIJ Health System, who is also a member of the New York State Department of Health Cardiac Advisory Committee.

LIJ is the only hospital in the state to perform a majority of angioplasty procedures using the radial approach, a technique in which the procedure is performed through the patient's wrist instead of the groin. The radial approach has been shown to reduce bleeding complications and allows for quicker walking after the procedure. The hospital's Cardiac Catheterization Lab is headed by Barry Kaplan, MD.

The DOH's full report can by found online at: http://www.health.state.ny.us/nysdoh/heart/heart_disease.htm. Scroll down to "percutaneous coronary interventions."


'/>"/>
SOURCE North Shore-LIJ Health System
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
8. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
9. Red wine compound shown to prevent prostate cancer
10. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
11. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company ... and full year ended December 31, 2015 on Monday, February 29, 2016 after the ... investment community following the release at 4:30 PM ET. Investors interested in participating by ...
(Date:2/10/2016)... Boston, Massachusetts (PRWEB) , ... February 10, 2016 ... ... practice models to effectively measure change in their patients. Research shows that the ... traditional methods. To help therapists overcome this challenge and learn more about the ...
(Date:2/10/2016)... Palm Beach, Florida (PRWEB) , ... February 10, ... ... & Country Club) announced that it has been awarded the prestigious Distinguished Emerald ... the World award program conducted by BoardRoom magazine, one of the most respected ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... 1 UNF Drive, Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions ... Division - Time: 7:00pm – 10:00pm | Ticket Prices $30, Social Media: ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of ... in the state still face a lot of restrictions as to where they can ... for private, personal use” and that cannabis “may not be consumed openly or publicly.” ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... February 10, 2016 --> ... (Liquid & Gas), and Spectroscopy Market by Industry (Oil & ... Pulp & Paper, Metal & Mining, and Others), And ... the global market is expected to grow to USD ... 8.6% between 2015 and 2020. Browse 82 ...
(Date:2/10/2016)... , Feb. 10, 2016 CSI Specialty ... with the launch of the Specialty Pharmacy Podcast. A ... industry-first, aimed at providing real-world education, discussion and context ... --> --> The Specialty ... CEO of CSI Specialty Group Suzette DiMascio, CHE, CMCE, ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... leader in viral gene therapy manufacturing, and Renova™ Therapeutics, ... heart failure and other chronic diseases, have entered into ... process and produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for ... --> --> This relationship will ...
Breaking Medicine Technology: